Most Read Articles
2 days ago
Transgender and gender nonconforming students are more likely to adopt poor health behaviours than their cisgender peers, a recent study has found.
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
6 days ago
Treatment with direct oral anticoagulant (DOAC) plus P2Y12 inhibitor (dual therapy) in adults with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) reduces bleeding risk compared with vitamin K antagonist plus aspirin and P2Y12 inhibitor (triple therapy), suggest a study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

Podcast: อายุรศาสตร์ โรคต่อมไร้ท่อมและเมตะบอลิสมโรงพยาบาลพระมงกุฎเกล้า

05 Mar 2020
Podcast: อายุรศาสตร์ โรคต่อมไร้ท่อมและเมตะบอลิสมโรงพยาบาลพระมงกุฎเกล้า
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Transgender and gender nonconforming students are more likely to adopt poor health behaviours than their cisgender peers, a recent study has found.
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
6 days ago
Treatment with direct oral anticoagulant (DOAC) plus P2Y12 inhibitor (dual therapy) in adults with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) reduces bleeding risk compared with vitamin K antagonist plus aspirin and P2Y12 inhibitor (triple therapy), suggest a study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.